Riverbridge Partners LLC Sells 69,341 Shares of Phreesia, Inc. (NYSE:PHR)

Riverbridge Partners LLC cut its position in shares of Phreesia, Inc. (NYSE:PHR) by 9.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 683,888 shares of the company’s stock after selling 69,341 shares during the quarter. Riverbridge Partners LLC’s holdings in Phreesia were worth $17,207,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PHR. Wesbanco Bank Inc. increased its holdings in Phreesia by 76.9% in the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after buying an additional 20,000 shares during the period. Franklin Resources Inc. increased its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after acquiring an additional 42,973 shares during the period. Geode Capital Management LLC raised its position in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. M&T Bank Corp lifted its stake in Phreesia by 4.6% during the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock worth $801,000 after purchasing an additional 1,535 shares during the period. Finally, Barclays PLC boosted its holdings in Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after purchasing an additional 43,225 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price target for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. KeyCorp lifted their price target on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research report on Friday, January 10th. Finally, Robert W. Baird reduced their target price on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $31.00.

Phreesia Stock Down 0.2 %

Shares of Phreesia stock opened at $27.29 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market capitalization of $1.59 billion, a P/E ratio of -18.56 and a beta of 0.94. The business has a 50-day moving average of $23.87 and a two-hundred day moving average of $22.97. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm’s revenue was up 16.6% compared to the same quarter last year. During the same period last year, the company earned ($0.58) earnings per share. As a group, equities analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Insider Activity

In other news, COO Evan Roberts sold 2,873 shares of the firm’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $26.61, for a total transaction of $76,450.53. Following the transaction, the chief operating officer now directly owns 779,993 shares of the company’s stock, valued at approximately $20,755,613.73. This trade represents a 0.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Weintraub sold 15,152 shares of Phreesia stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $21.01, for a total value of $318,343.52. Following the completion of the transaction, the director now directly owns 242,827 shares of the company’s stock, valued at $5,101,795.27. This represents a 5.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 131,756 shares of company stock valued at $3,244,909. 5.80% of the stock is owned by company insiders.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.